课题基金 / 基金详情

Water soluble variants of the human mu opioid receptor

Water soluble variants of the human mu opioid receptor
人类μ阿片受体的水溶性变体
批准号:
9027069
负责人:
Renyu Liu
金额:
$9.33万
依托单位:
依托单位国家:
美国
项目类别:
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-09-05 至 2019-08-31

项目摘要

项目成果

Renyu Liu的其他基金

相似基金

相关文献

中文摘要
翻译
点击翻译按钮获取中文摘要
英文摘要
DESCRIPTION (provided by applicant): Opioids remain the major medication for perioperative and chronic pain management despite their side effects, which include respiratory depression, constipation, addiction and others related to morbidity and mortality in our patients, as well as presenting a significant economic and political burden. Since both the analgesic and side effects are thought to arise from activation of the �-receptor (MUR), a better understanding of the structural and functional relationships of human MUR will provide clues in addressing this clinical dilemma. In this project, we will engineer water soluble variants of the human mu receptor (wsMUR) based on the newly available crystal structure of murine MUR, investigate the properties of the receptor in the presence or absence of N and C terminus, and establish a system in investigating the direct interaction of an opioid ligand with the receptor without needing radioactive ligands or mammalian cells. There are 2 major aims for this study. In specific aim 1, we will engineer and study a new generation of wsMUR based on the crystal structure of murine MUR along with our first version of engineered receptor published recently and establish a novel system in investigating the direct interaction of opioid and receptor by taking the advantages of wsMUR and surface plasmon resonance. In specific aim 2, we will computationally engineer variants of wsMURs by changing wide ranges of surface residues in the transmembrane region to test the following hypotheses: 1) There is a minimal requirement of the number of mutations enabling the human MUR to be expressed in E coli with a reasonable water solubility and comparable properties to its native form~ 2) The receptor may tolerate 35% of the mutations for the residues in the transmembrane portion based on our past experiences of protein engineering on the membrane proteins to maximize water solubility and improve monomeric states for future high resolution protein dynamics studies (i.e. nuclear magnetic resonance) in solution conditions~ 3) Removal of cysteine on the surface of the transmembrane portion of the receptor could reduce disulfide bond induced protein dimerization. This project not only provides various variants of wsMUR for structure function relationship studies, but also yields a novel system that can investigate the direct interaction between opioids and MUR, and offer a significant technology breakthrough. Thus, this project stands to elucidate the molecular mechanisms of MUR and aid in the identification of novel opioid analgesics with reduced side effects, improved pain control, and address issues related to opioid administration and abuse. This group has a track record in engineering water soluble membrane proteins. Professor Saven at the Department of Chemistry is an expert on protein engineering and Professor Liu at the Department of Anesthesiology is an expert on opioid receptors. The preliminary data for all the specific aims are promising.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Water soluble variants of the human mu opioid receptor
  • 批准号:
    9332409
  • 项目类别:
  • 资助金额:
    $31.66万
  • 财政年份:
    2014
  • 负责人:
    Renyu Liu
  • 依托单位:
Water soluble variants of the human mu opioid receptor
  • 批准号:
    8749007
  • 项目类别:
  • 资助金额:
    $31.69万
  • 财政年份:
    2014
  • 负责人:
    Renyu Liu
  • 依托单位:
Structural Approaches for Understanding Opioid and ??-Receptor Interactions
  • 批准号:
    8288784
  • 项目类别:
  • 资助金额:
    $12.63万
  • 财政年份:
    2010
  • 负责人:
    Renyu Liu
  • 依托单位:
Structural Approaches for Understanding Opioid and ??-Receptor Interactions
  • 批准号:
    8102993
  • 项目类别:
  • 资助金额:
    $12.63万
  • 财政年份:
    2010
  • 负责人:
    Renyu Liu
  • 依托单位:
海外基金